Profil
Cheri L.
Walker is currently Chief Executive Officer at Zeta Corp, Non-Executive Director at Atomo Diagnostics Ltd. since 2022, and Director at Cell IDx, Inc. Former positions include President, Chief Executive Officer & Director at Rhinostics, Inc. from 2020 to 2023; Vice President at Invitrogen Corp.; Analyst at Deutsche Bank Securities, Inc. from 2003 to 2005; Senior Vice President-Corporate Development and Senior Vice President at Charles River Laboratories International, Inc. and Charles River Laboratories, Inc.; Chief Commercial Officer at SeraCare Life Sciences, Inc.; Operating Executive at SFW Capital Partners LP; Vice President-Mergers & Acquisition at Qiagen, Inc. and QIAGEN Sciences, Inc.; and Vice President at Proteomics, Inc. Education includes undergraduate studies at Swarthmore College and a doctorate from Baylor College of Medicine.
Postes actifs de Cheri Walker
| Sociétés | Poste | Début |
|---|---|---|
| ATOMO DIAGNOSTICS LIMITED | Directeur/Membre du Conseil | 15/11/2022 |
Cell IDx, Inc.
Cell IDx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as multiplexed tissue profiling company that provides multiplex staining panels, tissue staining and imaging and analysis services | Directeur/Membre du Conseil | - |
Zeta Corp
Zeta Corp BiotechnologyHealth Technology Manufactures IVD antibodies | Directeur Général | - |
Anciens postes connus de Cheri Walker
| Sociétés | Poste | Fin |
|---|---|---|
Rhinostics, Inc.
Rhinostics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops automated nasal swab products | Directeur Général | 01/11/2023 |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 28/07/2005 |
SeraCare Life Sciences, Inc.
SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biological based products to serve the global life sciences industry | Corporate Officer/Principal | - |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Corporate Officer/Principal | - |
Proteomics, Inc. | Corporate Officer/Principal | - |
Formation de Cheri Walker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Electronic Technology |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing and research services on a contract basis | Commercial Services |
Charles River Laboratories, Inc.
Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research models and laboratory animal support services | Commercial Services |
SeraCare Life Sciences, Inc.
SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biological based products to serve the global life sciences industry | Health Technology |
Swarthmore College
Swarthmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SFW Capital Partners LP
SFW Capital Partners LP Investment ManagersFinance SFW Capital Partners invests in companies located in the United States with a revenue of USD 10 - 100 million and EBITDA of USD 3 - 20 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for MBOs, corporate carve-outs, recapitalizations and buyout, growth transactions with an investment size of USD 25 - 100 million. It acquires minority positions in the companies. | Finance |
Qiagen, Inc.
Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides technologies for separating, purifying and handling nucleic acids | Commercial Services |
QIAGEN Sciences, Inc.
QIAGEN Sciences, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures chemical products | Process Industries |
Proteomics, Inc. | |
Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. Medical SpecialtiesHealth Technology Manufactures and markets blood testing vitro diagnostic medical devices | Health Technology |
Cell IDx, Inc.
Cell IDx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as multiplexed tissue profiling company that provides multiplex staining panels, tissue staining and imaging and analysis services | Commercial Services |
Rhinostics, Inc.
Rhinostics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops automated nasal swab products | Commercial Services |
Zeta Corp
Zeta Corp BiotechnologyHealth Technology Manufactures IVD antibodies | Health Technology |
















